Identification of bioactive peptides and quantification of β-casomorphin-7 from bovine β-casein A1, A2 and I after ex vivo gastrointestinal digestion

International Dairy Journal

Volumn 71, Issue , 2017, Pages 98-106

  Asledottir, Tora ^a   Le, Thao T ^b   Petrat Melin, Bjørn ^b   Devold, Tove G ^a   Larsen, Lotte B ^b   Vegarud, Gerd E ^a  

^a NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN; GENES; MAMMALS; MASS SPECTROMETRY;

BIOACTIVE PEPTIDES; GASTROINTESTINAL DIGESTION; GENETIC VARIANTS; GENETIC VARIATION; MASS SPECTROMETRY ANALYSIS; SIMULATED DIGESTION; VITRO DIGESTION; VIVO MODELS;

PEPTIDES;

EID: 85017529802     PISSN: 09586946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idairyj.2017.03.008     Document Type: Article

References (58)

1. Barnett, M.P., McNabb, W.C., Roy, N.C., Woodford, K.B., Clarke, A.J., Dietary A1 beta-casein affects gastrointestinal transit time, dipeptidyl peptidase-4 activity, and inflammatory status relative to A2 beta-casein in Wistar rats. International Journal of Food Science and Nutrition 65 (2014), 720–727.
2. Boutrou, R., Gaudichon, C., Dupont, D., Jardin, J., Airinei, G., Marsset-Baglieri, A., et al. Sequential release of milk protein-derived bioactive peptides in the jejunum in healthy humans. American Journal of Clinical Nutrition 97 (2013), 1314–1323.
3. Brantl, V., Teschemacher, H., Bläsig, J., Henschen, A., Lottspeich, F., Opioid activities of β-casomorphins. Life Sciences 28 (1981), 1903–1909.
4. Caroli, A.M., Chessa, S., Erhardt, G.J., Invited review: Milk protein polymorphisms in cattle: Effect on animal breeding and human nutrition. Journal of Dairy Science 92 (2009), 5335–5352.
5. Cass, H., Gringras, P., March, J., McKendrick, I., O'Hare, A.E., Owen, L., et al. Absence of urinary opioid peptides in children with autism. Archives of Disease and Childhood 93 (2008), 745–750.
6. Chabance, B., Jolles, P., Izquierdo, C., Mazoyer, E., Francoual, C., Drouet, L., et al. Characterization of an antithrombotic peptide from kappa-casein in newborn plasma after milk ingestion. British Journal of Nutrition 73 (1995), 583–590.
7. Cieslinska, A., Kaminski, S., Kostyra, E., Sienkiewicz-Szlapka, E., Beta-casomorphin 7 in raw and hydrolyzed milk derived from cows of alternative β-casein genotypes. Milchwissenschaft 62 (2007), 125–127.
8. Cieslinska, A., Kostyra, E., Kostyra, H., Olenski, K., Fiedorowicz, E., Kaminski, S., Milk from cows of different beta-casein genotypes as a source of beta-casomorphin-7. International Journal of Food Science and Nutrition 63 (2012), 426–430.
9. De Magistris, L., Familiari, V., Pascotto, A., Sapone, A., Frolli, A., Iardino, P., et al. Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. Journal of Pediatric Gastroenterology and Nutrition 51 (2010), 418–424.
10. De Noni, I., Release of beta-casomorphins 5 and 7 during simulated gastro-intestinal digestion of bovine beta-casein variants and milk-based infant formulas. Food Chemistry 110 (2008), 897–903.
11. De Noni, I., Cattaneo, S., Occurrence of β-casomorphins 5 and 7 in commercial dairy products and in their digests following in vitro simulated gastro-intestinal digestion. Food Chemistry 119 (2010), 560–566.
12. Deat, E., Blanquet-Diot, S., Jarrige, J.F., Denis, S., Beyssac, E., Alric, M., Combining the dynamic TNO-gastrointestinal tract system with a Caco-2 cell culture model: Application to the assessment of lycopene and alpha-tocopherol bioavailability from a whole food. Journal of Agricultural and Food Chemistry 57 (2009), 11314–11320.
13. Deth, R., Clarke, A., Ni, J., Trivedi, M., Clinical evaluation of glutathione concentrations after consumption of milk containing different subtypes of beta-casein: Results from a randomized, cross-over clinical trial. Nutrition Journal, 15, 2016 Article 82.
14. Devle, H., Ulleberg, E.K., Naess-Andresen, C.F., Rukke, E.-O., Vegarud, G., Ekeberg, D., Reciprocal interacting effects of proteins and lipids during ex vivo digestion of bovine milk. International Dairy Journal 36 (2014), 6–13.
15. Dupont, D., Bordoni, A., Brodkorb, A., Capozzi, F., Cirkovic Velickovic, T., Corredig, M., et al. Food Digestion 2 (2011), 23–25.
16. Edelhoch, H., Spectroscopic determination of tryptophan and tyrosine in proteins. Biochemistry 6 (1967), 1948–1954.
17. EFSA, Review of the potential health impact of β-casomorphins and related peptides. EFSA Scientific Report 231 (2009), 1–107.
18. Eisele, T., Stressler, T., Kranz, B., Fischer, L., Bioactive peptides generated in an enzyme membrane reactor using Bacillus lentus alkaline peptidase. European Food Research and Technology 236 (2013), 483–490.
19. Elliott, R.B., Harris, D.P., Hill, J.P., Bibby, N.J., Wasmuth, H.E., Type I (insulin-dependent) diabetes mellitus and cow milk: Casein variant consumption. Diabetologia 42 (1999), 292–296.
20. Eriksen, E.K., Holm, H., Jensen, E., Aaboe, R., Devold, T.G., Jacobsen, M., et al. Different digestion of caprine whey proteins by human and porcine gastrointestinal enzymes. British Journal of Nutrition 104 (2010), 374–381.
21. Foltz, M., Cerstiaens, A., van Meensel, A., Mols, R., van der Pijl, P.C., Duchateau, G.S., et al. The angiotensin converting enzyme inhibitory tripeptides Ile-Pro-Pro and Val-Pro-Pro show increasing permeabilities with increasing physiological relevance of absorption models. Peptides 29 (2008), 1312–1320.
22. Gallinat, J.L., Qanbari, S., Drogemuller, C., Pimentel, E.C., Thaller, G., Tetens, J., DNA-based identification of novel bovine casein gene variants. Journal of Dairy Science 96 (2013), 699–709.
23. Gobbetti, M., Ferranti, P., Smacchi, E., Goffredi, F., Addeo, F., Production of angiotensin-I-converting-enzyme-inhibitory peptides in fermented milks started by Lactobacillus delbrueckii subsp. bulgaricus SS1 and Lactococcus lactis subsp. cremoris FT4. Applied and Environmental Microbiology 66 (2000), 3898–3904.
24. Guerra, A., Etienne-Mesmin, L., Livrelli, V., Denis, S., Blanquet-Diot, S., Alric, M., Relevance and challenges in modeling human gastric and small intestinal digestion. Trends in Biotechnology 30 (2012), 591–600.
25. Hernández-Ledesma, B., Amigo, L., Ramos, M., Recio, I., Release of angiotensin converting enzyme-inhibitory peptides by simulated gastrointestinal digestion of infant formulas. International Dairy Journal 14 (2004), 889–898.
26. Hunter, L.C., O'Hare, A., Herron, W.J., Fisher, L.A., Jones, G.E., Opioid peptides and dipeptidyl peptidase in autism. Developmental Medicine and Child Neurology 45 (2003), 121–128.
27. Islam, M.A., Ekeberg, D., Rukke, E.O., Vegarud, G.E., Ex vivo digestion of milk from Red Chittagong cattle focusing proteolysis and lipolysis. Asian-Australasian Journal of Animal Sciences 28 (2015), 559–567.
28. Iwan, M., Jarmolowska, B., Bielikowicz, K., Kostyra, E., Kostyra, H., Kaczmarski, M., Transport of micro-opioid receptor agonists and antagonist peptides across Caco-2 monolayer. Peptides 29 (2008), 1042–1047.
29. Jenness, R., Koops, J., Preparation and properties of salt solution which simulates milk ultrafiltrate. Netherlands Milk and Dairy Journal 16 (1962), 153–164.
30. Jensen, H.B., Poulsen, N.A., Andersen, K.K., Hammershoj, M., Poulsen, H.D., Larsen, L.B., Distinct composition of bovine milk from Jersey and Holstein-Friesian cows with good, poor, or noncoagulation properties as reflected in protein genetic variants and isoforms. Journal of Dairy Science 95 (2012), 6905–6917.
31. Jianqin, S., Leiming, X., Lu, X., Yelland, G.W., Ni, J., Clarke, A.J., Effects of milk containing only A2 β-casein versus milk containing both A1 and A2 β-casein proteins on gastrointestinal physiology, symptoms of discomfort, and cognitive behavior of people with self-reported intolerance to traditional cows' milk. Nutrition Journal, 15, 2016 Article 35.
32. Jinsmaa, Y., Yoshikawa, M., Enzymatic release of neocasomorphin and β-casomorphin from bovine β-casein. Peptides 20 (1999), 957–962.
33. Lahrichi, S.L., Affolter, M., Zolezzi, I.S., Panchaud, A., Food peptidomics: Large scale analysis of small bioactive peptides – A pilot study. Journal of Proteomics 88 (2013), 83–91.
34. Minekus, M., Alminger, M., Alvito, P., Ballance, S., Bohn, T., Bourlieu, C., et al. A standardised static in vitro digestion method suitable for food – An international consensus. Food and Function 5 (2014), 1113–1124.
35. Nagpal, R., Behare, P., Rana, R., Kumar, A., Kumar, M., Arora, S., et al. Bioactive peptides derived from milk proteins and their health beneficial potentials: An update. Food and Function 2 (2011), 18–27.
36. Nguyen, D.D., Johnson, S.K., Busetti, F., Solah, V.A., Formation and degradation of β-casomorphins in dairy processing. Critical Reviews in Food Science and Nutrition 55 (2015), 1955–1967.
37. Nongonierma, A.B., FitzGerald, R.J., Bioactive properties of milk proteins in humans: A review. Peptides 73 (2015), 20–34.
38. Osborne, S., Chen, W., Addepalli, R., Colgrave, M., Singh, T., Tran, C., et al. In vitro transport and satiety of a beta-lactoglobulin dipeptide and beta-casomorphin-7 and its metabolites. Food and Function 5 (2014), 2706–2718.
39. O'Mahony, J.A., Fox, P.F., Milk proteins: Introduction and historical aspects., 4th ed. McSweeney, P.L.H., Fox, P.F., (eds.) Advanced dairy chemistry. Vol. 1A. Proteins: Basic aspects, 2013, Springer US, Boston, MA, USA, 43–85.
40. Pal, S., Woodford, K., Kukuljan, S., Ho, S., Milk intolerance, β-casein and lactose. Nutrients 7 (2015), 7285–7297.
41. Petrat-Melin, B., Characterization of the in vitro digestion and bioactive potential of bovine beta-and kappa-casein variants. PhD thesis, 2014, Aarhus University, Aarhus, Denmark Retrieved from http://pure.au.dk/portal/files/82371598/PhD_thesis_Bj_rn_Petrat_Melin_FOOD_AU.pdf.
42. Petrat-Melin, B., Andersen, P., Rasmussen, J.T., Poulsen, N.A., Larsen, L.B., Young, J.F., In vitro digestion of purified beta-casein variants A(1), A(2), B, and I: Effects on antioxidant and angiotensin-converting enzyme inhibitory capacity. Journal of Dairy Science 98 (2015), 15–26.
43. Petrat-Melin, B., Le, T.T., Møller, H.S., Larsen, L.B., Young, J.F., Short communication: Inhibition of angiotensin 1-converting enzyme by peptides derived from variants of bovine β-casein upon apical exposure to a Caco-2 cell monolayer. Journal of Dairy Science 100 (2017), 881–885.
44. Quirós, A., Dávalos, A., Lasunción, M.A., Ramos, M., Recio, I., Bioavailability of the antihypertensive peptide LHLPLP: Transepithelial flux of HLPLP. International Dairy Journal 18 (2008), 279–286.
45. Quirós, A., Ramos, M., Muguerza, B., Delgado, M.A., Miguel, M., Aleixandre, A., et al. Identification of novel antihypertensive peptides in milk fermented with Enterococcus faecalis. International Dairy Journal 17 (2007), 33–41.
46. Rawlings, N.D., Barrett, A.J., Finn, R., Twenty years of the MEROPS database of proteolytic enzymes, their substrates and inhibitors. Nucleic Acids Research 44 (2016), D343–D350.
47. Saito, T., Nakamura, T., Kitazawa, H., Kawai, Y., Itoh, T., Isolation and structural analysis of antihypertensive peptides that exist naturally in Gouda cheese. Journal of Dairy Science 83 (2000), 1434–1440.
48. Sánchez-Rivera, L., Ares, I., Miralles, B., Gómez-Ruiz, J.A., Recio, I., Martínez-Larranaga, M.R., et al. Bioavailability and kinetics of the antihypertensive casein-derived peptide HLPLP in rats. Journal of Agricultural and Food Chemistry 62 (2014), 11869–11875.
49. Sánchez-Rivera, L., Santos, P.F., Miralles, B., Carrón, R., José Montero, M., Recio, I., Peptide fragments from β-casein f(134–138), HLPLP, generated by the action of rat blood plasma peptidases show potent antihypertensive activity. Food Research International 88 (2016), 348–353.
50. Sandré, C., Gleizes, A., Forestier, F., Gorges-Kergot, R., Chilmonczyk, S., Léonil, J., et al. A peptide derived from bovine beta-casein modulates functional properties of bone marrow-derived macrophages from germfree and human flora-associated mice. Journal of Nutrition 131 (2001), 2936–2942.
51. Schmelzer, C.E.H., Schöps, R., Reynell, L., Ulbrich-Hofmann, R., Neubert, R.H., Raith, K., Peptic digestion of β-casein. Time course and fate of possible bioactive peptides. Journal of Chromatography A 1166 (2007), 108–115.
52. Schmelzer, C.E.H., Schöps, R., Ulbrich-Hofmann, R., Neubert, R.H.H., Raith, K., Mass spectrometric characterization of peptides derived by peptic cleavage of bovine β-casein. Journal of Chromatography A 1055 (2004), 87–92.
53. Silva, S.V., Malcata, F.X., Caseins as source of bioactive peptides. International Dairy Journal 15 (2005), 1–15.
54. Tailford, K., Berry, C.L., Thomas, A.C., Campbell, J.H., A casein variant in cow's milk is atherogenic. Atherosclerosis 170 (2003), 13–19.
55. Tang, J., Specificity of pepsin and its dependence on a possible hydrophobic binding site. Nature 199 (1963), 1094–1095.
56. Ul Haq, M.R., Kapila, R., Kapila, S., Release of beta-casomorphin-7/5 during simulated gastrointestinal digestion of milk beta-casein variants from Indian crossbred cattle (Karan Fries). Food Chemistry 168 (2015), 70–79.
57. Ulleberg, E.K., Comi, I., Holm, H., Herud, E.B., Jacobsen, M., Vegarud, G.E., Human gastrointestinal juices intended for use in in vitro digestion models. Food Digestion 2 (2011), 52–61.
58. Xu, R.J., Bioactive peptides in milk and their biological and health implications. Food Reviews International 14 (1998), 1–16.